ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
ICRA assigned a new [ICRA]BBB (Stable) rating to Infinium Pharmachem's ₹52.20 Crore credit facilities. The assignment covers cash credit, term loans, and unallocated limits from ICICI Bank and SBI.
Infinium Pharmachem Limited held its 22nd Annual General Meeting on September 17, 2026. Shareholders transacted ordinary and special business, including director appointments and remuneration revisions.
Infinium Pharmachem Limited issued a postal ballot notice to seek shareholder approval for migrating its equity shares from the NSE Emerge platform to the main board.
Infinium Pharmachem Limited issued a notice for its Annual General Meeting to be held on September 17, 2026. The meeting agenda includes financial statement adoption and director re-appointments.
Infinium Pharmachem Limited has appointed M/s. Ronak R Jain & Associates as Internal Auditor and M/s. RTBR & Associates as Secretarial Auditor. The company also re-appointed BRS & Associates as Cost Auditor.
Infinium Pharmachem Limited has appointed an Internal Auditor, Secretarial Auditor, and Cost Auditor for the Financial Year 2026-27 to comply with statutory regulatory requirements.
Infinium Pharmachem's board approved migrating from the NSE SME platform to the Main Board, set the AGM date, and appointed new auditors for the upcoming fiscal year.
Infinium Pharmachem Limited has scheduled a board meeting for August 22, 2026, to discuss other business matters.